EW
Published on 05/28/2025 at 17:43
Health-care companies slipped as the sector continued to lag the broad market for the year to date.
Medical-device maker Edwards Lifesciences shares ticked up after rival Boston Scientific said it would stop selling its rival heart-valve replacement systems. The systems, called transcatheter aortic heart-valve replacements, or TAVR, are a means of replacing faulty heart valves without resorting to open-heart surgery.
Shares of Big Pharma companies continued a recent retreat amid concerns that the sector could face more regulation on Robert F. Kennedy Jr.'s watch as head of Health and Human Services.
Write to Rob Curran at [email protected]
(END) Dow Jones Newswires
05-28-25 1742ET